Skip to main content

An obscure FDA rule aiding blockbuster drug profits

An FDA rule created to spur drug companies to develop treatments for rare diseases is being used far beyond its original scope, critics say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.